Design

Navigating the Landscape of Different NGS Platforms: A Comprehensive Guide
he development of next-generation sequencing (NGS) over the past 15 to 20 years has seen multiple technologies rapidly leapfrogging each other’s milestones to sequence more DNA faster, cheaper, and more accurately. While Illumina sequencers still predominate, other NGS providers are gaining ground, providing important alternative options for sequencing mechanisms, read lengths, run times, ease-of-use, and scalability. This article aims to guide researchers through the main differences among today’s common NGS platforms, with a special focus on the offerings from Capitalbio Technology.

https://www.capitalbiotechnology.com/navigating-the-landscape-of-different-ngs-platforms-a-comprehensive-guide.html